The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prognostic significance of therapy-induced myelosuppression in newly diagnosed glioblastoma.
 
Michael Weller
Honoraria - Adastra Pharmaceuticals; Merck Serono; Nerviano Medical Sciences; Philogen
Consulting or Advisory Role - Bristol-Myers Squibb; Karyopharm Therapeutics; Medac; Orbus Therapeutics; Ymabs Therapeutics Inc
Research Funding - Apogenix (Inst); Merck Serono (Inst); Merck Sharp & Dohme (Inst); Novocure (Inst); Quercegen Pharmaceuticals (Inst)
 
Felix Boakye Oppong
No Relationships to Disclose
 
Maureen Vanlancker
No Relationships to Disclose
 
Roger Stupp
Stock and Other Ownership Interests - Alpheus Medical
Consulting or Advisory Role - AstraZeneca; Boston Biomedical; Boston Scientific; Carthera; Celgene; Celularity; CranioVation; GT Medical Technologies; Hemispherian; InSightec; Northwest Biotherapeutics; Novocure; The Lockwood Group; Triact Therapeutics; Zai Lab
Research Funding - Bristol-Myers Squibb/Celgene (Inst); CarThera
Patents, Royalties, Other Intellectual Property - METHODS OF DETERMINING RESPONSIVENESS TO CHEMOTHERAPEUTIC COMPOUNDS FOR CANCER THERAPY Type: Provisional Serial No. 63/202,761 Filed: 6/23/2021 (Inst)
 
Louis B. Nabors
Consulting or Advisory Role - Chimerix
Patents, Royalties, Other Intellectual Property - Development of novel inhibitors to HuR through NCI funded peer reviewed research.
Other Relationship - cns pharmaceuticals; University of Pennsylvania
 
Olivier L. Chinot
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb
 
Wolfgang Wick
Consulting or Advisory Role - MSD Oncology (Inst); Roche/Genentech (Inst)
Research Funding - Apogenix (Inst); Pfizer (Inst); Roche (Inst)
 
Matthias Preusser
Consulting or Advisory Role - Abbvie; AstraZeneca; Bayer; BMJ Journals; Bristol-Myers Squibb; CMC Contrast; Daiichi Sankyo; Gerson Lehrman Group; GlaxoSmithKline; Lilly; Medahead; MedMedia; Merck Sharp & Dohme; Mundipharma; Novartis; Roche; Sanofi; Tocagen
Research Funding - Abbvie (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); GlaxoSmithKline (Inst); Merck Sharp & Dohme (Inst); Novocure (Inst); Roche (Inst)
 
Thierry Gorlia
No Relationships to Disclose
 
Emilie Le Rhun
Consulting or Advisory Role - Adastra Pharmaceuticals; Bayer; Leo Pharma; Seagen